NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Distribution · USD

Accendra Health, Inc. (ACH) Stock Analysis

Accendra Health, Inc. (ACH) is a Medical Distribution stock listed on NYSE and quoted in US Dollar.

ACH

$1.21

−$0.01 (−0.82%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ACH with… →

ACH Key Statistics

As of Sep 4, 2026
Trading
Open
$1.21
Previous Close
$1.22
Day's Range
1.19–1.22
52-Week Range
0.93–5.69
Volume
339.20K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.52
Valuation
Market Cap
$93.05M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
8.08
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.70
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.04
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.45
Financials (FY)
Revenue (FY)
$2.76B+3.06%
Net Income (FY)
−$1.10B
Profit marginThe share of revenue left as profit after all costs and taxes.
−11.41%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
76.90M
1-Year Return
−77.59%
Dividend and dates
Earnings Date
October 29, 2026estimated
Avg Volume
1.16M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ACH Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−56.79%
2025−78.58%
2024−32.17%
2023−1.33%
2022−55.10%
2021+60.86%
2020+423.96%
2019−18.11%
2018−64.51%
2017−44.44%
2016 (partial year)+2.28%

As of September 4, 2026.

ACH Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.76B−$1.10B−39.8%
2024$2.68B−$362.69M−13.5%
2023$2.55B−$41.30M−1.6%
2022$9.96B$22.39M0.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.76B$1.29B$221.74M−$1.10B−39.8%
2024$2.68B$1.28B$198.04M−$362.69M−13.5%
2023$2.55B$1.22B$215.36M−$41.30M−1.6%
2022$9.96B$1.83B$276.78M$22.39M0.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ACH Valuation vs Medical Distribution Median

Median of 13 stocks
MetricACHMedical Distribution medianvs median
P/S ratio0.040.360.1x the median
Profit margin−11.41%−4.03%7.4 pts below

Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 11 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Accendra Health, Inc. (ACH) at $93.05M. It is classified in the Medical Distribution industry, within the Healthcare sector. Headcount on file is 6,500.

ACH last closed at $1.21 on September 4, 2026. That is −$0.01 (−0.82%) against the previous close. Over the past 52 weeks the price has ranged from $0.93 to $5.69. The latest close sits 30.11% above that 52-week low.

Financial Health

In fiscal 2025, Accendra Health, Inc. reported revenue of $2.76B. Against the prior fiscal year total of $2.68B, that is a change of +3.06%. The same year closed with a net loss of $1.10B. The reported profit margin is −11.41%. That is 7.4 percentage points below the Medical Distribution median of −4.03%. Trailing earnings per share are −1.45.

Across the 4 fiscal years on file, revenue moves from $9.96B in 2022 to $2.76B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 8.08. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.7. Measured against sales, the shares trade at 0.04 times revenue. On price-to-sales that is 0.1 times the Medical Distribution median of 0.36. 13 Medical Distribution companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.53. Annualized volatility over the trailing 10 years is 79.52%. The trailing one-year price return is −77.59%. Measured over 10 years, that is −27.70% a year compounded.

Growth & Income

The record shows no dividend for ACH.

2026 is still running; the price is −56.79% year to date. Across the complete calendar years on file, 2020 returned +423.96% and 2025 returned −78.58%. Of the 9 complete calendar years on file, 2 finished higher.

Peer Comparison

Accendra Health, Inc. (ACH) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Accendra Health, Inc. ACH $93.05M —
McKesson Corporation MCK $105.86B 24.7
Cencora, Inc. COR $63.15B 25.1
Cardinal Health, Inc. CAH $57.49B 34.4

The Medical Distribution industry average P/E ratio is 25.8x. Accendra Health, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$105.86B

 COR

Cencora, Inc.

$63.15B

 CAH

Cardinal Health, Inc.

$57.49B

 HSIC

Henry Schein, Inc.

$10.01B

 AHG

Akso Health Group

$726.49M

 FOCL

EDAP TMS S.A.

$190.70M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Accendra Health, Inc.

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Visit website →